Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1273

1.

Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy.

Hancock SB, Krempl GA, Canfield V, Bogardus C, Kojouri K, Kaneaster SK, Medina JE.

Laryngoscope. 2008 Aug;118(8):1357-61. doi: 10.1097/MLG.0b013e318175336a.

PMID:
18528311
[PubMed - indexed for MEDLINE]
2.

Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.

Cmelak AJ, Murphy BA, Burkey B, Douglas S, Shyr Y, Netterville J.

Head Neck. 2007 Apr;29(4):315-24.

PMID:
17252600
[PubMed - indexed for MEDLINE]
3.

Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV).

Wanebo HJ, Chougule P, Ready N, Koness RJ, Akerley W, McRae R, Nigri P, Leone L, Webber B, Safran H.

Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):77-84.

PMID:
10210544
[PubMed - indexed for MEDLINE]
4.

Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.

Malone JP, Stephens JA, Grecula JC, Rhoades CA, Ghaheri BA, Schuller DE.

Head Neck. 2004 Jul;26(7):561-72.

PMID:
15229898
[PubMed - indexed for MEDLINE]
5.

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma.

Shin DM, Khuri FR, Glisson BS, Ginsberg L, Papadimitrakopoulou VM, Clayman G, Lee JJ, Ang KK, Lippman SM, Hong WK.

Cancer. 2001 Apr 1;91(7):1316-23.

PMID:
11283932
[PubMed - indexed for MEDLINE]
6.

Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM.

Semin Oncol. 1998 Apr;25(2 Suppl 4):40-4; discussion 45-8.

PMID:
9578061
[PubMed - indexed for MEDLINE]
7.

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.

Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E Jr, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK.

Cancer. 2002 Jul 15;95(2):322-30.

PMID:
12124833
[PubMed - indexed for MEDLINE]
Free Article
8.

Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.

Mantovani G, Ghiani M, Lai P, Maccio A, Dessi D, Succu G, Massa D, Curreli L, Mulas C, Esu S, Proto E, Cadeddu G, Tore G.

Oncol Rep. 1998 Nov-Dec;5(6):1499-505.

PMID:
9769395
[PubMed - indexed for MEDLINE]
9.

Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.

Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H, Rosenthal DI, Gillison M, Forastiere AA.

J Clin Oncol. 2007 Sep 1;25(25):3971-7.

PMID:
17761982
[PubMed - indexed for MEDLINE]
10.
11.

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.

Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB.

Cancer. 2009 Oct 1;115(19):4514-23. doi: 10.1002/cncr.24525.

PMID:
19634161
[PubMed - indexed for MEDLINE]
Free Article
12.

Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV).

Wanebo H, Chougule P, Ready N, Safran H, Ackerley W, Koness RJ, McRae R, Nigri P, Leone L, Radie-Keane K, Reiss P, Kennedy T.

Ann Surg Oncol. 2001 Sep;8(8):644-50.

PMID:
11569779
[PubMed - indexed for MEDLINE]
13.

Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.

Zanetta G, Fei F, Mangioni C.

Semin Oncol. 2000 Feb;27(1 Suppl 1):23-7. Review.

PMID:
10697040
[PubMed - indexed for MEDLINE]
14.

Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.

Wanebo HJ, Glicksman AS, Landman C, Slotman G, Doolittle C, Clark J, Koness RJ.

Am J Surg. 1995 Nov;170(5):512-6.

PMID:
7485745
[PubMed - indexed for MEDLINE]
15.

Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research Network.

Hainsworth JD, Meluch AA, McClurkan S, Gray JR, Stroup SL, Burris HA 3rd, Yardley DA, Bradof JE, Yost K, Ellis JK, Greco FA.

Cancer J. 2002 Jul-Aug;8(4):311-21.

PMID:
12184409
[PubMed - indexed for MEDLINE]
16.

Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.

Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J.

Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):861-7.

PMID:
15262764
[PubMed - indexed for MEDLINE]
17.

Prognostic value of response to preoperative chemoradiotherapy and residual tumor grades in tongue carcinoma.

Kirita T, Shimooka H, Yamanaka Y, Tatebayashi S, Yamamoto K, Nishimine M, Sugimura M.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Mar;91(3):293-300.

PMID:
11250626
[PubMed - indexed for MEDLINE]
18.

Surgical treatment of squamous cell carcinoma of the base of tongue.

Gourin CG, Johnson JT.

Head Neck. 2001 Aug;23(8):653-60.

PMID:
11443748
[PubMed - indexed for MEDLINE]
19.

Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.

Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.

J Clin Oncol. 2004 Aug 1;22(15):3061-9.

PMID:
15284256
[PubMed - indexed for MEDLINE]
20.

Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.

Athanasiadis I, Taylor S 4th, Vokes EE, Pelzer HJ, Rademaker A, Mittal BB, Ganzenko N, Blough R, Lester EP, Kies MS.

Cancer. 1997 Feb 1;79(3):588-94.

PMID:
9028372
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk